期刊文献+

APA-BCCs微胶囊移植对晚期癌症患者的镇痛效果评价 被引量:13

Clinical evaluation of analgesic effect of APA-BCCs xenotransplantation in patients with advanced cancer
在线阅读 下载PDF
导出
摘要 目的:评价海藻酸钠-聚赖氨酸-海藻酸钠(APA)微囊化牛肾上腺嗜铬细胞(BCC)移植于患者蛛网膜下腔后的镇痛效果。方法:分4个剂量组:微胶囊0.5×107,1.0×107,1.25×107,1.5×107/(次·例)。采用腰椎穿刺术,将生理盐水稀释后的微胶囊注入20例中、重度癌痛患者L3~4或L4~5蛛网膜下腔内。结果:移植后第1~5天开始起效,移植前疼痛强度(数字分级法)为7.8±1.5,移植后降至2.5±2.3(P<0.05)。镇痛总有效率在0.5×107,1.0×107,1.25×107,1.5×107/(次·例)剂量组分别为:66%,100%,80%,66%。镇痛持续中位时间24d,最长持续时间>120d。移植后患者生活质量评分较移植前升高10分(P>0.05)。结论:APA-BCCs微胶囊蛛网膜下腔移植治疗中、重度癌痛具有起效较快、长效镇痛的特点。 AIM:To evaluate the analgesic effect of Alginate Polylysine Alyinate(APA)miroencapsulated bovine chromaffin cells(BCCs) xenotransplantated into spinal subarachnoid space of cancer patients. METHODS:Twenty cases were randomly divided into four groups: 0.5×107 cells per time group,1.0×107 cells per time group,1.25×107 cells per time group and 1.5×107 cells per time group.APA BCCs which were diluted by saline were slowly injected into the spinal subarachnoid space L3-4 or L4-5 of patients who suffered from moderate or severe cancer pain with lumbar puncture. RESULTS:The analgesic effect was apparent 5 days after xenotransplantation, and pain intensity (numerical pain intensity scale) descended from 7.8±1.5 to 2.5±2.3(P< 0.05).The total analgesic effective rates were 66%,100%,80%,66% respectively in 0.5×107,1.0×107,1.25×107,1.5×107cells per time group. The medium time of analgesia lasted 24 days, and the longest time over 120 days.The patients' quality of life improved 10 scores as compared with that of protransplantation(P >0.05). CONCLUSION:Xenotransplantation of APA BCCs into the spinal subarachnoid space against moderate and severe caner pain can be relieved promptly and stably.
出处 《中国临床康复》 CSCD 2004年第20期3953-3955,共3页 Chinese Journal of Clinical Rehabilitation
基金 国家八六三计划项目基金(2002AA216141) 军队"十五"重点项目基金资助课题(01Z031)~~
  • 相关文献

参考文献9

二级参考文献35

  • 1高军茂 薛毅珑 等.微囊化牛嗜铬细胞移植于偏侧帕金森病样大鼠脑内的实验研究-Ⅰ行为和组织学[J].中华器官移植杂志,1990,20:10-10.
  • 2高军茂,中华器官移植杂志,1999年,20卷,10页
  • 3Unsicker K,Krieglstein K. Growth factors in chromaffin cells.Prog in Neurobio, 1996,48:307~324.
  • 4Sagen J,Pappas GD,Perlow MJ. Alterations in nociception following adrenal medullary transplants into the rat periaqueductal gray. Expl Brain Reserch, 1987,67:373~379.
  • 5Schueler S,Ortega J,Sagen J,et al. Robust survival of isolated bovine adrenal chromaffin cells following intrastriatal transplantation:A novel hypothesis of adrenal graft viability. J Neurosc, 1993,13:4496~4510.
  • 6Ortega J,Sagen J,Pappas GD. Short-term immunosuppression enhances long-terms survival of bovine chromaffin cell xenografts in rat CNS. Cell transpl, 1992,1:33~41.
  • 7Joseph JM,Goddard MB,Mills J,et al.Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space:a preclinical study for the treatment of cancer pain.Cell Transpl, 1994,5:355~364.
  • 8Wu H,Mcloon SC, Wilcox G.Antinociception following implantation of mouse pituitary AtT-20 cells ands genetically modified AtT-20/hEnk cells in rat spinal cord. J Neurosci, 1993,14:4806~4814.
  • 9Aebischer P,Tresco P,winn SR,et al. Long-term cross-species brain transplantation of a ploymer encapsulated dopamine-secreting cell line. Exp Neurol, 1991,111:269~275.
  • 10Bennett GJ,Xie YK. A periphetal mononeuropatgh in rats that produces disorders of pain sensation like those seen in human. Pain,1988,33:87~107.

共引文献34

同被引文献151

引证文献13

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部